A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response
John R. Bankston, Minerva Yue, Wendy Chung et al. · 2007
Read A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response by John R. Bankston, Minerva Yue, Wendy Chung et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001258.txt.
Description
Long QT syndrome is an inherited heart rhythm disorder that can kill without warning. John Bankston and colleagues report the case of a newborn carrying a new mutation, in a 2007 PLOS ONE article. The mutation sits in SCN5A, the gene for the heart's main sodium channel, and caused the variant called LQT-3.
The authors describe the de novo mutation as novel and lethal, with distinct molecular pharmacology and a distinct therapeutic response. De novo means it appeared fresh in the child, not inherited. Working out how this channel variant answers to drugs guided treatment of a very young patient.
Catalog record
| CREATOR | John R. Bankston, Minerva Yue, Wendy Chung et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001258